tradingkey.logo
搜索

Twist Bioscience Corp

TWST
添加自选
99.240USD
-3.010-2.94%
收盘 07/02, 13:00美东报价延迟15分钟
6.17B总市值
亏损市盈率 TTM

关于 Twist Bioscience Corp 公司

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp简介

公司代码TWST
公司名称Twist Bioscience Corp
上市日期Oct 31, 2018
CEOLeproust (Emily M)
员工数量979
证券类型Ordinary Share
年结日Oct 31
公司地址681 Gateway Blvd.
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94080
电话18007190671
网址https://www.twistbioscience.com/
公司代码TWST
上市日期Oct 31, 2018
CEOLeproust (Emily M)

Twist Bioscience Corp公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.75K
-16.90%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
7.12K
-84.57%
Ms. Trynka Shineman Blake
Ms. Trynka Shineman Blake
Director
Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%

常见问题

Twist Bioscience Corp的前五大股东是谁?

Twist Bioscience Corp 的前五大股东如下:Dr. Emily M. Leproust, Ph.D.

有多少机构持有Twist Bioscience Corp(TWST)的股份?

截至2026Q1,共有592家机构持有Twist Bioscience Corp的股份,合计持有的股份价值约为78.48M,占公司总股份的126.03%。与2025Q4相比,机构持股有所增加,增幅为-339291.00。

哪个业务部门对Twist Bioscience Corp的收入贡献最大?

在2026Q1,NGS applications业务部门对Twist Bioscience Corp的收入贡献最大,创收52.64M,占总收入的50.76%。